CSS
NVAX icon

Cubist Systematic Strategies’s Novavax NVAX Stock Holding History

Cubist Systematic Strategies’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$815K Hold
94,000
– – ﹤0.01% 2041
2025
Q2 		$592K Hold
94,000
– – ﹤0.01% 2185
2025
Q1 		$603K Sell
94,000
-5,300
-5% -$43.8K ﹤0.01% 2082
2024
Q4 		$798K Buy
99,300
+10,700
+12% +$103K 0.01% 1935
2024
Q3 		$1.12M Buy
+88,600
New +$1.14M 0.01% 1764

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cubist Systematic Strategies's NVAX Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Novavax (NVAX) stake by 69% in Q3 2025, selling an estimated $3.83M and leaving 221,540 shares worth $1.92M. The position accounts for 0.01% of the portfolio, ranked #1593.

Cubist Systematic Strategies first reported a position in NVAX in Q3 2014 and has held it in 26 quarters since. The position peaked at $5.04M in Q4 2022. 250 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Cubist Systematic Strategies held 221,540 shares of Novavax worth $1.92M as of Q3 2025.
  • Cubist Systematic Strategies sold 492,146 Novavax shares in Q3 2025, an estimated $3.83M.
  • Novavax made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1593 holding.
  • Cubist Systematic Strategies first reported a position in Novavax in Q3 2014 and has held it in 26 quarters since.
  • Cubist Systematic Strategies's Novavax position peaked at $5.04M in Q4 2022.
  • 250 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.